174 related articles for article (PubMed ID: 18331150)
1. Cluster randomized trials with treatment noncompliance.
Jo B; Asparouhov T; Muthén BO; Ialongo NS; Brown CH
Psychol Methods; 2008 Mar; 13(1):1-18. PubMed ID: 18331150
[TBL] [Abstract][Full Text] [Related]
2. Intention-to-treat analysis in cluster randomized trials with noncompliance.
Jo B; Asparouhov T; Muthén BO
Stat Med; 2008 Nov; 27(27):5565-77. PubMed ID: 18623608
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
Park S; Kürüm E
Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
[TBL] [Abstract][Full Text] [Related]
5. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
6. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials.
Gomes M; Ng ES; Grieve R; Nixon R; Carpenter J; Thompson SG
Med Decis Making; 2012; 32(2):350-61. PubMed ID: 22016450
[TBL] [Abstract][Full Text] [Related]
7. Statistical power in randomized intervention studies with noncompliance.
Jo B
Psychol Methods; 2002 Jun; 7(2):178-93. PubMed ID: 12090409
[TBL] [Abstract][Full Text] [Related]
8. An introduction to spillover effects in cluster randomized trials with noncompliance.
Keele L; Kang H
Clin Trials; 2022 Aug; 19(4):375-379. PubMed ID: 35510562
[TBL] [Abstract][Full Text] [Related]
9. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
Taylor L; Zhou XH
Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
11. Sample size determination for testing equality in a cluster randomized trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2011 Jan; 21(1):1-17. PubMed ID: 21191850
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian hierarchical model estimating CACE in meta-analysis of randomized clinical trials with noncompliance.
Zhou J; Hodges JS; Suri MFK; Chu H
Biometrics; 2019 Sep; 75(3):978-987. PubMed ID: 30690716
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of estimands in clinical trials with imperfect compliance.
Chen H; Heitjan DF
Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
[TBL] [Abstract][Full Text] [Related]
14. Imputation strategies for missing binary outcomes in cluster randomized trials.
Ma J; Akhtar-Danesh N; Dolovich L; Thabane L;
BMC Med Res Methodol; 2011 Feb; 11():18. PubMed ID: 21324148
[TBL] [Abstract][Full Text] [Related]
15. Estimating causal effects of treatment in RCTs with provider and subject noncompliance.
Sheng E; Li W; Zhou XH
Stat Med; 2019 Feb; 38(5):738-750. PubMed ID: 30347462
[TBL] [Abstract][Full Text] [Related]
16. Multiple imputation by predictive mean matching in cluster-randomized trials.
Bailey BE; Andridge R; Shoben AB
BMC Med Res Methodol; 2020 Mar; 20(1):72. PubMed ID: 32228491
[TBL] [Abstract][Full Text] [Related]
17. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
18. Handling missing data in randomized experiments with noncompliance.
Jo B; Ginexi EM; Ialongo NS
Prev Sci; 2010 Dec; 11(4):384-96. PubMed ID: 20379779
[TBL] [Abstract][Full Text] [Related]
19. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
Boatman JA; Vock DM; Koopmeiners JS
Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
[TBL] [Abstract][Full Text] [Related]
20. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
Merrill PD; McClure LA
Trials; 2015 Nov; 16():523. PubMed ID: 26573840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
